Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use

2021-01-19 12:04:34

FILE PHOTO: A booth displaying a coronavirus disease (COVID-19) Human Immunoglobulin for Intravenous Injection from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 4, 2020. [Photo/Agencies] ISLAMABAD - Pakistan on Monday approved the Chinese Sinopharm COVID-19 vaccine for emergency use, a government statement said. The Drug Regulatory Authority Pakistan (DRAP) said the vaccine, manufactured by China National Pharmaceutical Group (SinoPharm), had been given emergency use approval (EUA). The authority had approved AstraZeneca's vaccine, developed with Oxford University, for emergency use at the weekend. Pakistan's health ministry has said the country was in process of speaking to different vaccine candidates. Reuters